{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn some embodiments, an antigen binding moiety has a high affinity for an antigen target (e.g., a K<sub>D </sub>of less than about 10<sup>\u22127 </sup>M, less than about 10<sup>\u22128 </sup>M, or less than about 10<sup>\u22129 </sup>M))."}
{"final_json": [{"molecule_name": null, "protein_target_name": "antigen", "binding_metric": "Kd", "value": "<10^\u22127", "unit": "M"}, {"molecule_name": null, "protein_target_name": "antigen", "binding_metric": "Kd", "value": "<10^\u22128", "unit": "M"}, {"molecule_name": null, "protein_target_name": "antigen", "binding_metric": "Kd", "value": "<10^\u22129", "unit": "M"}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text appears to be a descriptive passage defining various terms and concepts, but it does not contain specific molecule names, bioactivity metrics, numeric values, and units as required."}
{"raw_mentions": "In certain embodiments, an antibody described herein exhibits high affinity for binding an antigen (e.g., CLL-1) with a K<sub>D </sub>of less than about 10<sup>\u22124</sup>, 10<sup>\u22125</sup>, 10<sup>\u22126</sup>, 10<sup>\u22127</sup>, 10<sup>\u22128</sup>, 10<sup>\u22129</sup>, 10<sup>\u221210</sup>, 10<sup>\u221211</sup>, 10<sup>\u221212</sup>, 10<sup>\u221213</sup>, 10<sup>\u221214</sup>, or 10<sup>\u221215</sup>M.\nIn certain instances, K<sub>D </sub>of an antibody as described herein for an antigen (e.g., CLL-1) is between 0.001 and 1 nM, e.g., 0.001 nM, 0.005 nM, 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, or 1 nM."}
{"final_json": [{"molecule_name": "antibody", "protein_target_name": "CLL-1", "binding_metric": "Kd", "value": "<10^\u22124", "unit": "M"}, {"molecule_name": "antibody", "protein_target_name": "CLL-1", "binding_metric": "Kd", "value": "0.001", "unit": "nM"}, {"molecule_name": "antibody", "protein_target_name": "CLL-1", "binding_metric": "Kd", "value": "0.005", "unit": "nM"}, {"molecule_name": "antibody", "protein_target_name": "CLL-1", "binding_metric": "Kd", "value": "0.01", "unit": "nM"}, {"molecule_name": "antibody", "protein_target_name": "CLL-1", "binding_metric": "Kd", "value": "0.05", "unit": "nM"}, {"molecule_name": "antibody", "protein_target_name": "CLL-1", "binding_metric": "Kd", "value": "0.1", "unit": "nM"}, {"molecule_name": "antibody", "protein_target_name": "CLL-1", "binding_metric": "Kd", "value": "0.5", "unit": "nM"}, {"molecule_name": "antibody", "protein_target_name": "CLL-1", "binding_metric": "Kd", "value": "1", "unit": "nM"}, {"molecule_name": "antibody", "protein_target_name": "CLL-1", "binding_metric": "Kd", "value": "10^\u22125", "unit": "M"}, {"molecule_name": "antibody", "protein_target_name": "CLL-1", "binding_metric": "Kd", "value": "10^\u22126", "unit": "M"}, {"molecule_name": "antibody", "protein_target_name": "CLL-1", "binding_metric": "Kd", "value": "10^\u22127", "unit": "M"}, {"molecule_name": "antibody", "protein_target_name": "CLL-1", "binding_metric": "Kd", "value": "10^\u22128", "unit": "M"}, {"molecule_name": "antibody", "protein_target_name": "CLL-1", "binding_metric": "Kd", "value": "10^\u22129", "unit": "M"}, {"molecule_name": "antibody", "protein_target_name": "CLL-1", "binding_metric": "Kd", "value": "10^\u221210", "unit": "M"}, {"molecule_name": "antibody", "protein_target_name": "CLL-1", "binding_metric": "Kd", "value": "10^\u221211", "unit": "M"}, {"molecule_name": "antibody", "protein_target_name": "CLL-1", "binding_metric": "Kd", "value": "10^\u221212", "unit": "M"}, {"molecule_name": "antibody", "protein_target_name": "CLL-1", "binding_metric": "Kd", "value": "10^\u221213", "unit": "M"}, {"molecule_name": "antibody", "protein_target_name": "CLL-1", "binding_metric": "Kd", "value": "10^\u221214", "unit": "M"}, {"molecule_name": "antibody", "protein_target_name": "CLL-1", "binding_metric": "Kd", "value": "10^\u221215", "unit": "M"}]}
{"raw_mentions": "The Leu16scFv-CD19 construct had a Kd of \u02dc3 nm whereas the Rituximab-based construct, i.e. the full Rituximab mAb, had a Kd of \u02dc16 pM."}
{"final_json": [{"molecule_name": "Leu16scFv-CD19", "protein_target_name": "CD19", "binding_metric": "Kd", "value": "\u02dc3", "unit": "nm"}, {"molecule_name": "Rituximab", "protein_target_name": "CD19", "binding_metric": "Kd", "value": "\u02dc16", "unit": "pM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The binding EC50 of construct #357 was less than construct #330 (control), which was less then EC50 of construct #186.\n* As shown in FIGS. 47A and 47B, the killing EC50 of construct #357 was much less than construct #186 or #330."}
{"final_json": [{"molecule_name": "construct #357", "protein_target_name": null, "binding_metric": "EC50", "value": "<", "unit": null}, {"molecule_name": "construct #357", "protein_target_name": null, "binding_metric": "killing EC50", "value": "<", "unit": null}]}
